Wikisage, the free encyclopedia of the second generation, is digital heritage
Hippel-Lindau disease: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
<ref>Pschryrembel Klinisches Worterbuch</ref> | <ref>Pschryrembel Klinisches Worterbuch</ref> | ||
[[File:Vhl n1.jpg|thumb|VHL protein]] | |||
{{refs}} | {{refs}} | ||
[[Category:Medicine]] | [[Category:Medicine]] | ||
Revision as of 00:05, 14 August 2021
Disease classification WHO
Q85.8 Hippel-Lindau Syndrome
H L syndrome also known as Hippel-Lindau disease, occasionally also called retino-cerebellar angiomatosis, is a rare, hereditary tumor disease from the group of so-called phakomatoses. Patients develop benign, tumor-like tissue changes (angiomas) primarily in the area of the retina of the eye and the cerebellum. The latter has also been referred to as Lindau tumor or Lindau syndrome.[1] The disease was named after the Göttingen ophthalmologist Eugen von Hippel (1867-1939) and the Swedish pathologist Arvid Lindau (1892-1958). Von Hippel first described angiomas of the eye in 1904, Lindau angiomas in the spinal cord in 1926 [2]
| References: |
|